AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 37 filers reported holding AC IMMUNE SA in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,293 | -5.5% | 59,752 | -2.0% | 0.00% | – |
| Q2 2023 | $180,113 | +66.4% | 60,952 | +31.8% | 0.00% | – |
| Q1 2023 | $108,218 | +140.5% | 46,247 | +263.9% | 0.00% | – |
| Q2 2022 | $45,000 | -11.8% | 12,707 | 0.0% | 0.00% | – |
| Q1 2022 | $51,000 | -19.0% | 12,707 | 0.0% | 0.00% | – |
| Q4 2021 | $63,000 | -25.9% | 12,707 | 0.0% | 0.00% | – |
| Q3 2021 | $85,000 | -15.8% | 12,707 | 0.0% | 0.00% | – |
| Q2 2021 | $101,000 | +4.1% | 12,707 | 0.0% | 0.00% | – |
| Q1 2021 | $97,000 | +47.0% | 12,707 | 0.0% | 0.00% | – |
| Q4 2020 | $66,000 | +6.5% | 12,707 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -27.9% | 12,707 | 0.0% | 0.00% | – |
| Q2 2020 | $86,000 | +10.3% | 12,707 | +12.5% | 0.00% | – |
| Q1 2020 | $78,000 | – | 11,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 11,297,911 | $55,925,000 | 5.88% |
| Prosight Management, LP | 1,248,453 | $6,180,000 | 3.43% |
| PA Capital LLC | 76,257 | $377,000 | 0.37% |
| Artal Group S.A. | 1,000,000 | $4,950,000 | 0.20% |
| Temasek Holdings (Private) Ltd | 2,614,095 | $12,940,000 | 0.10% |
| COHEN LAWRENCE B | 13,350 | $66,000 | 0.04% |
| Tekla Capital Management LLC | 171,813 | $850,000 | 0.04% |
| Athanor Capital, LP | 108,540 | $537,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 28,600 | $142,000 | 0.02% |
| APPLETON PARTNERS INC/MA | 11,525 | $57,000 | 0.01% |